StonvexLoading…
StonvexStonvexStonvexCore line items from LEG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $997.71M | $918.20M | $4.06B | $3.12B | $2.08B |
Operating Income | Not available | $31.90M | $289.70M | $271.20M | $116.80M |
Net Income | Not available | $20.00M | $235.40M | $210.20M | $83.10M |
EPS (Diluted) | $0.28 | $0.14 | $1.69 | $1.51 | $0.60 |
Total Assets | Not available | $3.52B | $3.54B | $3.52B | $3.70B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $510.50M | $587.40M | $460.70M | $368.80M |
Free Cash Flow OCF − CapEx | Not available | $-80.40M | $281.00M | $179.10M | $69.00M |
Shares Outstanding | Not available | 141.00M | 139.70M | 139.50M | 139.10M |